healthstop healthcare limited Company Information
Company Number
04721226
Next Accounts
Dec 2025
Shareholders
kmw pharma ltd
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
healthstop pharmacy, 168 hamstead road, birmingham, B20 2QR
Website
-healthstop healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of HEALTHSTOP HEALTHCARE LIMITED at £93.1k based on a Turnover of £315.9k and 0.29x industry multiple (adjusted for size and gross margin).
healthstop healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of HEALTHSTOP HEALTHCARE LIMITED at £6.6k based on an EBITDA of £1.9k and a 3.38x industry multiple (adjusted for size and gross margin).
healthstop healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of HEALTHSTOP HEALTHCARE LIMITED at £82.4k based on Net Assets of £39.5k and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Healthstop Healthcare Limited Overview
Healthstop Healthcare Limited is a live company located in birmingham, B20 2QR with a Companies House number of 04721226. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in April 2003, it's largest shareholder is kmw pharma ltd with a 100% stake. Healthstop Healthcare Limited is a mature, micro sized company, Pomanda has estimated its turnover at £315.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Healthstop Healthcare Limited Health Check
Pomanda's financial health check has awarded Healthstop Healthcare Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs


2 Strong

4 Regular

6 Weak

Size
annual sales of £315.9k, make it smaller than the average company (£12.6m)
- Healthstop Healthcare Limited
£12.6m - Industry AVG

Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (7.4%)
- Healthstop Healthcare Limited
7.4% - Industry AVG

Production
with a gross margin of 26.5%, this company has a comparable cost of product (31.4%)
- Healthstop Healthcare Limited
31.4% - Industry AVG

Profitability
an operating margin of 0.6% make it less profitable than the average company (2.6%)
- Healthstop Healthcare Limited
2.6% - Industry AVG

Employees
with 2 employees, this is below the industry average (64)
2 - Healthstop Healthcare Limited
64 - Industry AVG

Pay Structure
on an average salary of £26.7k, the company has an equivalent pay structure (£26.7k)
- Healthstop Healthcare Limited
£26.7k - Industry AVG

Efficiency
resulting in sales per employee of £158k, this is equally as efficient (£146.1k)
- Healthstop Healthcare Limited
£146.1k - Industry AVG

Debtor Days
it gets paid by customers after 71 days, this is later than average (29 days)
- Healthstop Healthcare Limited
29 days - Industry AVG

Creditor Days
its suppliers are paid after 136 days, this is slower than average (63 days)
- Healthstop Healthcare Limited
63 days - Industry AVG

Stock Days
it holds stock equivalent to 25 days, this is in line with average (32 days)
- Healthstop Healthcare Limited
32 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 35 weeks, this is more cash available to meet short term requirements (13 weeks)
35 weeks - Healthstop Healthcare Limited
13 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 71.3%, this is a higher level of debt than the average (58.6%)
71.3% - Healthstop Healthcare Limited
58.6% - Industry AVG
HEALTHSTOP HEALTHCARE LIMITED financials

Healthstop Healthcare Limited's latest turnover from March 2024 is estimated at £315.9 thousand and the company has net assets of £39.5 thousand. According to their latest financial statements, Healthstop Healthcare Limited has 2 employees and maintains cash reserves of £59 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 2 | 6 | 6 | 6 | 5 | 5 | 7 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 13,432 | 17,909 | 23,879 | 31,839 | 2,452 | 3,269 | 2,301 | 3,069 | 4,093 | 1,916 | 2,554 | 2,992 | 3,781 | ||
Intangible Assets | 20,000 | 40,000 | 60,000 | 80,000 | 100,000 | 120,000 | 140,000 | 160,000 | 180,000 | 200,000 | 220,000 | 240,000 | 260,000 | ||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 33,432 | 57,909 | 83,879 | 111,839 | 102,452 | 123,269 | 142,301 | 163,069 | 184,093 | 201,916 | 222,554 | 242,992 | 263,781 | ||
Stock & work in progress | 16,500 | 37,154 | 37,154 | 37,154 | 37,154 | 45,765 | 44,745 | 44,322 | 39,274 | 46,191 | 54,483 | 51,896 | 45,226 | 54,584 | |
Trade Debtors | 62,185 | 156,061 | 96,449 | 99,684 | 111,594 | 80,218 | 98,885 | 73,638 | 73,976 | 207,376 | 132,219 | 136,086 | 160,877 | 153,926 | 165,967 |
Group Debtors | |||||||||||||||
Misc Debtors | 19,899 | 19,793 | 33,463 | 284,207 | 357,335 | 400,303 | 284,718 | ||||||||
Cash | 59,010 | 81,137 | 522,740 | 587,991 | 445,947 | 148,260 | 93,313 | 21,782 | 85,744 | 202,307 | 220,087 | 242,673 | 180,713 | 116,172 | 254,232 |
misc current assets | |||||||||||||||
total current assets | 137,695 | 237,198 | 676,242 | 744,622 | 628,158 | 549,839 | 595,298 | 540,468 | 488,760 | 448,957 | 398,497 | 433,242 | 393,486 | 315,324 | 474,783 |
total assets | 137,695 | 237,198 | 709,674 | 802,531 | 712,037 | 661,678 | 697,750 | 663,737 | 631,061 | 612,026 | 582,590 | 635,158 | 616,040 | 558,316 | 738,564 |
Bank overdraft | 231,041 | 162,382 | 174,520 | 186,784 | 199,061 | 210,991 | |||||||||
Bank loan | |||||||||||||||
Trade Creditors | 86,661 | 201,953 | 83,063 | 76,740 | 84,081 | 103,252 | 100,130 | 103,230 | 88,905 | 392,589 | 377,201 | 444,758 | 478,782 | 455,793 | 461,148 |
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 40,833 | 29,707 | 49,771 | 35,935 | 94,979 | 89,047 | 89,350 | ||||||||
total current liabilities | 86,661 | 201,953 | 123,896 | 337,488 | 296,234 | 313,707 | 381,893 | 391,338 | 389,246 | 392,589 | 377,201 | 444,758 | 478,782 | 455,793 | 461,148 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 11,573 | ||||||||||||||
provisions | 2,392 | 3,207 | 4,382 | 5,758 | 83 | 83 | 83 | 83 | 83 | 83 | 145 | 148 | 213 | ||
total long term liabilities | 11,573 | 2,392 | 3,207 | 4,382 | 5,758 | 83 | 83 | 83 | 83 | 83 | 83 | 145 | 148 | 213 | |
total liabilities | 98,234 | 201,953 | 126,288 | 340,695 | 300,616 | 319,465 | 381,976 | 391,421 | 389,329 | 392,672 | 377,284 | 444,841 | 478,927 | 455,941 | 461,361 |
net assets | 39,461 | 35,245 | 583,386 | 461,836 | 411,421 | 342,213 | 315,774 | 272,316 | 241,732 | 219,354 | 205,306 | 190,317 | 137,113 | 102,375 | 277,203 |
total shareholders funds | 39,461 | 35,245 | 583,386 | 461,836 | 411,421 | 342,213 | 315,774 | 272,316 | 241,732 | 219,354 | 205,306 | 190,317 | 137,113 | 102,375 | 277,203 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 4,477 | 4,477 | 960 | 10,613 | 817 | 1,090 | 768 | 1,024 | 1,365 | 638 | 853 | 997 | 1,261 | ||
Amortisation | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | |||||||
Tax | |||||||||||||||
Stock | 16,500 | -37,154 | -8,611 | 1,020 | 423 | 5,048 | -6,917 | -8,292 | 2,587 | 6,670 | -9,358 | 54,584 | |||
Debtors | -93,876 | 39,713 | -3,129 | -25,580 | -219,368 | -91,795 | -17,721 | 115,247 | 151,318 | 75,157 | -3,867 | -24,791 | 6,951 | -12,041 | 165,967 |
Creditors | -115,292 | 118,890 | 6,323 | -7,341 | -19,171 | 3,122 | -3,100 | 14,325 | -303,684 | 15,388 | -67,557 | -34,024 | 22,989 | -5,355 | 461,148 |
Accruals and Deferred Income | -40,833 | 11,126 | -20,064 | 13,836 | -59,044 | 5,932 | -303 | 89,350 | |||||||
Deferred Taxes & Provisions | -2,392 | -815 | -1,175 | -1,376 | 5,675 | -62 | -3 | -65 | 213 | ||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | 11,573 | ||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -22,127 | -441,603 | -65,251 | 142,044 | 297,687 | 54,947 | 71,531 | -63,962 | -116,563 | -17,780 | -22,586 | 61,960 | 64,541 | -138,060 | 254,232 |
overdraft | -231,041 | 68,659 | -12,138 | -12,264 | -12,277 | -11,930 | 210,991 | ||||||||
change in cash | -22,127 | -441,603 | 165,790 | 73,385 | 309,825 | 67,211 | 83,808 | -52,032 | -327,554 | -17,780 | -22,586 | 61,960 | 64,541 | -138,060 | 254,232 |
healthstop healthcare limited Credit Report and Business Information
Healthstop Healthcare Limited Competitor Analysis

Perform a competitor analysis for healthstop healthcare limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in B20 area or any other competitors across 12 key performance metrics.
healthstop healthcare limited Ownership
HEALTHSTOP HEALTHCARE LIMITED group structure
Healthstop Healthcare Limited has no subsidiary companies.
Ultimate parent company
HEALTHSTOP HEALTHCARE LIMITED
04721226
healthstop healthcare limited directors
Healthstop Healthcare Limited currently has 2 directors. The longest serving directors include Miss Maria Ashiq (Nov 2022) and Mrs Khizra Ashiq (Nov 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Miss Maria Ashiq | England | 35 years | Nov 2022 | - | Director |
Mrs Khizra Ashiq | England | 36 years | Nov 2022 | - | Director |
P&L
March 2024turnover
315.9k
-72%
operating profit
1.9k
0%
gross margin
26.5%
-2.89%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
39.5k
+0.12%
total assets
137.7k
-0.42%
cash
59k
-0.27%
net assets
Total assets minus all liabilities
healthstop healthcare limited company details
company number
04721226
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
April 2003
age
22
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
March 2024
previous names
N/A
accountant
MYRTLE GUND LTD
auditor
-
address
healthstop pharmacy, 168 hamstead road, birmingham, B20 2QR
Bank
-
Legal Advisor
-
healthstop healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to healthstop healthcare limited. Currently there are 1 open charges and 0 have been satisfied in the past.
healthstop healthcare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HEALTHSTOP HEALTHCARE LIMITED. This can take several minutes, an email will notify you when this has completed.
healthstop healthcare limited Companies House Filings - See Documents
date | description | view/download |
---|